Oncology Drug Development and Approval of Systemic Anticancer Therapy by the U.S. Food and Drug Administration

af Martell, Robert E., Sermer, David, Getz, Kenneth, Kaitin, Kenneth I.
Udgivet 2013

Cost sharing for breast cancer hormone therapy: How do dual eligible patients’ copayment impact adherence

af Ma, Siyu, Shepard, Donald S., Ritter, Grant A., Martell, Robert E., Thomas, Cindy Parks
Udgivet i PLoS One (2021)

Metformin, diabetes, and survival among US veterans with colorectal cancer

af Paulus, Jessica K., Williams, Christina D., Cossor, Furha I., Kelley, Michael J., Martell, Robert E.
Udgivet i Cancer Epidemiol Biomarkers Prev (2016)

Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer – Response to Letter

af Paulus, Jessica K., Williams, Christina D., Cossor, Furha I., Kelley, Michael J., Martell, Robert E.
Udgivet i Cancer Epidemiol Biomarkers Prev (2017)

Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies

af Godara, Amandeep, Siddiqui, Nauman S., Hachem, Hilal, Tsichlis, Philip N., Martell, Robert E., Saif, Muhammad Wasif
Udgivet i J Cell Signal (2020)

The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism

af Buglio, Daniela, Mamidipudi, Vidya, Khaskhely, Noor M., Brady, Helen, Heise, Carla, Besterman, Jeffrey, Martell, Robert E., MacBeth, Kyle, Younes, Anas
Udgivet 2010

EVALUATION OF THE PHARMACODYNAMIC EFFECTS OF MGCD0103 FROM PRECLINICAL MODELS TO HUMAN, USING A NOVEL HDAC ENZYME ASSAY

af Bonfils, Claire, Kalita, Ann, Dubay, Marja, Siu, Lillian L., Carducci, Michael A., Reid, Gregory, Martell, Robert E., Besterman, Jeffrey M., Li, Zuomei
Udgivet 2008

Diabetes, Metformin Use, and Colorectal Cancer Survival in Postmenopausal Women

af Cossor, Furha Iram, Adams-Campbell, Lucile L., Chlebowski, Rowan T., Gunter, Marc J, Johnson, Karen, Martell, Robert E., McTiernan, Anne, Simon, Michael S., Rohan, Thomas, Wallace, Robert B., Paulus, Jessica K.
Udgivet 2013

Phase II Study of the Histone Deacetylase Inhibitor MGCD0103 in Patients with Previously Treated Chronic Lymphocytic Leukemia

af Blum, Kristie A., Advani, Anjani, Fernandez, Louis, Van Der Jagt, Richard, Brandwein, Joseph, Kambhampati, Suman, Kassis, Jeannine, Davis, Melanie, Bonfils, Claire, Dubay, Marja, Dumouchel, Julie, Drouin, Michel, Lucas, David M., Martell, Robert E., Byrd, John C.
Udgivet 2009

Phase II Study of Mocetinostat (MGCD0103) In Patients with Relapsed and Refractory Classical Hodgkin Lymphoma

af Younes, Anas, Oki, Yasuhiro, Bociek, R. Gregory, Kuruvilla, John, Fanale, Michelle, Neelapu, Sattva, Copeland, Amanda, Buglio, Daniela, Galal, Ahmed, Besterman, Jeffrey, Li, Zuomei, Drouin, Michel, Patterson, Tracy, Ward, M. Renee, Paulus, Jessica K., Ji, Yuan, Medeiros, L. Jeffrey, Martell, Robert E.
Udgivet i Lancet Oncol (2011)

Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors

af Siu, Lillian L., Pili, Roberto, Duran, Ignacio, Messersmith, Wells A., Chen, Eric X., Sullivan, Rana, MacLean, Martha, King, Serina, Brown, Shirley, Reid, Gregory K., Li, Zuomei, Kalita, Ann M., Laille, Eric J., Besterman, Jeffrey M., Martell, Robert E., Carducci, Michael A.
Udgivet 2008

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

af Garcia-Manero, Guillermo, Assouline, Sarit, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Yang, Hui, Newsome, Willie M., Miller, Wilson H., Rousseau, Caroline, Kalita, Ann, Bonfils, Claire, Dubay, Marja, Patterson, Tracy-Ann, Li, Zuomei, Besterman, Jeffrey M., Reid, Gregory, Laille, Eric, Martell, Robert E., Minden, Mark
Udgivet 2008